Add BrightSurf on Google Email

Stanford Medicine


Leukemia stem cells identified by Stanford researchers

Researchers at Stanford Medicine have identified leukemia stem cells in chronic myelogenous leukemia, a breakthrough that could lead to new targeted therapies. The discovery reveals that normal adult cells can mutate into cancer stem cells, which are resistant to chemotherapy and require a specific protein called Wnt to self-renew.

SourceStanford Medicine·JournalNew England Journal of Medicine·DateAug 11, 2004

Gene-based screen sorts cancer cases, say Stanford researchers

A new gene-based screen developed by Stanford researchers can accurately predict a person's response to treatment and identify patients who may benefit from novel therapies. The screen uses a technique called RT-PCR to analyze genes associated with cancer survival, offering a more accessible alternative to existing microarray technology.

SourceStanford Medicine·JournalNew England Journal of Medicine·DateApr 28, 2004

Ethics of boosting brainpower debated by researchers

A group of researchers has outlined the ethical issues raised by modern neuroscience, including the use of plastic surgery and neural enhancement. The panel argues that treating illnesses rather than healthy individuals is more acceptable, but raises questions about the long-term effects of brain-altering medications like Ritalin.

SourceStanford Medicine·JournalNature Reviews Neuroscience·DateApr 19, 2004